“…During murine cardiogenesis, Gja5 is selectively expressed in the atrial myocardium, the ventricular conduction system, and the arterial endothelial cells (Beyer et al, 2011;Christoffels and Moorman, 2009;van Weerd and Christoffels, 2016). Cardiac Gja5 expression depends on Nkx2-5 (Dupays et al, 2005;Espinoza-Lewis et al, 2011;Linhares et al, 2004) but is repressed by Shox2 (Blaschke et al, 2007;Espinoza-Lewis et al, 2009), and is controlled tightly by the Shox2-Nkx2-5 antagonism in the Nkx2-5 + /Shox2 + domains (Li et al, 2019;Ye et al, 2015).…”